Resultados da busca - Muzaffar H. Qazilbash
- Mostrando 1 - 20 resultados de 59
- Ir para a próxima página
-
1
-
2
-
3
Durable remission with salvage second autotransplants in patients with multiple myeloma por Nina Shah, Fraz Ahmed, Qaiser Bashir, Sofia Qureshi, Yvonne Dinh, Gabriela Rondón, Sijin Wen, Peter F. Thall, Hassan Khan, Sergio Giralt, Richard Champlin, Muzaffar H. Qazilbash
Publicado em 2011Artigo -
4
Maintenance Therapy With Immunomodulatory Drugs in Multiple Myeloma: A Meta-Analysis and Systematic Review por Yucai Wang, Fang Yang, Yan Shen, Wenwen Zhang, Jacqueline Wang, Victor T. Chang, Börje S. Andersson, Muzaffar H. Qazilbash, Richard E. Champlin, James R. Berenson, Xiaoxiang Guan, Michael Wang
Publicado em 2015Revisão -
5
Moderate Renal Function Impairment Does Not Affect Outcomes of Reduced-Intensity Conditioning with Fludarabine and Melphalan for Allogeneic Hematopoietic Stem Cell Transplantation por Jonas A. de Souza, Rima M. Saliba, Poliana Patah, Gabriela Rondón, Rachel Ribeiro, Leandro de Pádua Silva, Muzaffar H. Qazilbash, Chitra Hosing, Uday Popat, Yvonne A. Efebera, Richard E. Champlin, Marcos de Lima
Publicado em 2009Artigo -
6
Hyperacute GVHD: risk factors, outcomes, and clinical implications por Rima M. Saliba, Marcos de Lima, Sergio Giralt, Börje S. Andersson, Issa F. Khouri, Chitra Hosing, Shubhra Ghosh, J. Neumann, Yvonne Hsu, Jorge de Jesús, Muzaffar H. Qazilbash, Richard E. Champlin, Daniel R. Couriel
Publicado em 2006Artigo -
7
Inflammatory Markers and Development of Symptom Burden in Patients with Multiple Myeloma during Autologous Stem Cell Transplantation por Xin Shelley Wang, Qiuling Shi, Nina Shah, Cobi J. Heijnen, Evan N. Cohen, James M. Reuben, Robert Z. Orlowski, Muzaffar H. Qazilbash, Valen E. Johnson, Loretta A. Williams, Tito R. Mendoza, Charles S. Cleeland
Publicado em 2014Artigo -
8
Steroid-Refractory Acute GVHD: Predictors and Outcomes por Jason R. Westin, Rima M. Saliba, Marcos de Lima, Amin Alousi, Chitra Hosing, Muzaffar H. Qazilbash, Issa F. Khouri, Elizabeth J. Shpall, Paolo Anderlini, Gabriela Rondón, Börje S. Andersson, R. E. Champlin, Daniel R. Couriel
Publicado em 2011Artigo -
9
Central nervous system involvement in blastic plasmacytoid dendritic cell neoplasm por Naveen Pemmaraju, Nathaniel R. Wilson, Joseph D. Khoury, Nitin Jain, Naval Daver, Sherry Pierce, Elias Jabbour, Tapan M. Kadia, Courtney D. DiNardo, Guillermo Garcia‐Manero, Muzaffar H. Qazilbash, Marina Konopleva, Hagop M. Kantarjian
Publicado em 2021Carta -
10
Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019 por Nicole Baranda Balmaceda, Muhammad Aziz, Viveksandeep Thoguluva Chandrasekar, Brian McClune, Suman Kambhampati, Leyla Shune, Al-Ola Abdallah, Faiz Anwer, Aneela Majeed, Muzaffar H. Qazilbash, Siddhartha Ganguly, Joseph P. McGuirk, Ghulam Rehman Mohyuddin
Publicado em 2021Revisão -
11
Post‐transplantation cyclophosphamide versus conventional graft‐versus‐host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation por Rohtesh S. Mehta, Rima M. Saliba, Julianne Chen, Gabriela Rondón, Aimee Hammerstrom, Amin M. Alousi, Muzaffar H. Qazilbash, Qaiser Bashir, Sairah Ahmed, Uday Popat, Chitra Hosing, Issa F. Khouri, Elizabeth J. Shpall, Richard E. Champlin, Stefan O. Ciurea
Publicado em 2016Artigo -
12
Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia por Limei Poon, Roland L. Bassett, Gabriela Rondón, Amir Hamdi, Muzaffar H. Qazilbash, Chitra Hosing, R B Jones, Elizabeth J. Shpall, Uday Popat, Yago Nieto, Laura L. Worth, Laurence J.N. Cooper, Marcos de Lima, R. Champlin, Partow Kebriaei
Publicado em 2012Artigo -
13
Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation with Sorafenib por Manish Sharma, Farhad Ravandi, Ulas D. Bayraktar, Alexandre Chiattone, Qaiser Bashir, Sergio Giralt, Julianne Chen, Muzaffar H. Qazilbash, Partow Kebriaei, Marina Konopleva, Michael Andreeff, Jorge E. Cortés, Deborah McCue, Hagop M. Kantarjian, Richard E. Champlin, Marcos de Lima
Publicado em 2011Artigo -
14
Poor hematopoietic stem cell mobilizers: A single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma por Chitra Hosing, Rima M. Saliba, Sheena Ahlawat, Martin Körbling, Partow Kebriaei, Amin M. Alousi, Marcos de Lima, Julia‐Grace Okoroji, John D. McMannis, Muzaffar H. Qazilbash, Paolo Anderlini, Sergio Giralt, Richard E. Champlin, Issa F. Khouri, Uday Popat
Publicado em 2009Artigo -
15
Autologous Hematopoietic Stem Cell Transplantation May Reverse Renal Failure in Patients with Multiple Myeloma por Gaurav Parikh, Ali Imran Amjad, Rima M. Saliba, Syed Mohammad Ali Kazmi, Ziad U. Khan, Amit Lahoti, Chitra Hosing, Floralyn Mendoza, S. Qureshi, Donna M. Weber, Michael Wang, Uday Popat, Amin M. Alousi, Richard E. Champlin, Sergio Giralt, Muzaffar H. Qazilbash
Publicado em 2009Artigo -
16
Outcomes of Adults with Acute Lymphoblastic Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation por Li Mei Poon, Amir Hamdi, Rima M. Saliba, Gabriela Rondón, Celina Ledesma, Monique Kendrick, Muzaffar H. Qazilbash, Chitra Hosing, Roy B. Jones, Uday Popat, Yago Nieto, Amin M. Alousi, Stefan O. Ciurea, Elizabeth J. Shpall, Richard E. Champlin, Partow Kebriaei
Publicado em 2013Artigo -
17
Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution por Chitra Hosing, Roland L. Bassett, B. Dabaja, R. Talpur, Amin M. Alousi, S Ciurea, U. Popat, Muzaffar H. Qazilbash, Elizabeth J. Shpall, Yasuhiro Oki, Yago Nieto, Chelsea C. Pinnix, Michelle A. Fanale, Farzaneh Maadani, Michèle L. Donato, Richard E. Champlin, Madeleine Duvic
Publicado em 2015Artigo -
18
Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD por Naveen Pemmaraju, Nathaniel R. Wilson, Guillermo Garcia‐Manero, Koji Sasaki, Joseph D. Khoury, Nitin Jain, Gautam Borthakur, Farhad Ravandi, Naval Daver, Tapan M. Kadia, Courtney D. DiNardo, Elias Jabbour, Sherry Pierce, Muzaffar H. Qazilbash, Marina Konopleva, Hagop M. Kantarjian
Publicado em 2022Artigo -
19
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease por Simrit Parmar, Marcos del Lima, Yizhou Zou, Poliana Patah, Ping Liu, Pedro Cano, Gabriela Rondón, Susana Pesoa, Leandro de Pádua Silva, Muzaffar H. Qazilbash, Chitra Hosing, Uday Popat, Partow Kebriaei, Elizabeth J. Shpall, Sergio Giralt, Richard E. Champlin, Peter Šťastný, Marcelo Fernández-Viña
Publicado em 2009Artigo -
20
Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome por Yago Nieto, Uday Popat, Paolo Anderlini, Ben C. Valdez, Börje S. Andersson, Ping Liu, Chitra Hosing, Elizabeth J. Shpall, Amin M. Alousi, Partow Kebriaei, Muzaffar H. Qazilbash, Simrit Parmar, Qaiser Bashir, Nina Shah, Issa F. Khouri, Gabriela Rondón, Richard E. Champlin, Roy B. Jones
Publicado em 2012Artigo
Ferramentas de busca:
Assuntos relacionados
Medicine
Internal medicine
Transplantation
Oncology
Surgery
Hematopoietic stem cell transplantation
Chemotherapy
Multiple myeloma
Biology
Immunology
Gastroenterology
Stem cell
Genetics
Melphalan
Autologous stem-cell transplantation
Cyclophosphamide
Physics
Confidence interval
Fludarabine
Graft-versus-host disease
Regimen
Busulfan
Cumulative incidence
Environmental health
Haematopoiesis
Hazard ratio
Leukemia
Population
Bone marrow
Cohort